1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ASAP1 CTRPv2 pan-cancer AAC -0.15 4e-05
mRNA LRRC8B CTRPv2 pan-cancer AAC 0.14 4e-05
mRNA BAZ1B CTRPv2 pan-cancer AAC 0.14 4e-05
mRNA HGFAC CTRPv2 pan-cancer AAC 0.13 4e-05
mRNA SDHD CTRPv2 pan-cancer AAC -0.14 4e-05
mRNA TULP4 CTRPv2 pan-cancer AAC 0.14 4e-05
mRNA ERGIC3 CTRPv2 pan-cancer AAC -0.13 4e-05
mRNA FADS2 CTRPv2 pan-cancer AAC 0.14 4e-05
mRNA GREB1 CTRPv2 pan-cancer AAC -0.14 4e-05
mRNA GNAZ CTRPv2 pan-cancer AAC 0.13 4e-05
Download CSV